Cerebral Metabolic Crisis in Pediatric Cerebral Malaria

Nicole F O'Brien1, Karen Chetcuti2, Yudy Fonseca3

  • 1Division of Critical Care Medicine, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, United States.

PubMed

Insights

Cerebral metabolic energy crisis (CMEC) is common in children with cerebral malaria (CM), with over half experiencing ischemic CMEC. This subtype is linked to poorer cerebral blood flow and worse neurological outcomes, suggesting potential therapeutic targets.

Area of Science:

  • Neurology
  • Pediatrics
  • Infectious Diseases

Background:

  • Cerebral metabolic energy crisis (CMEC), indicated by a high cerebrospinal fluid (CSF) lactate:pyruvate ratio (LPR), is linked to poor neurological outcomes.
  • Cerebral malaria (CM) is a major cause of childhood mortality and neurodisability globally.
  • The occurrence and characteristics of CMEC in pediatric CM patients remain underexplored.

Purpose of the Study:

  • To determine the frequency of CMEC in children with CM.
  • To differentiate between ischemic and nonischemic CMEC subtypes.
  • To investigate the association between CMEC subtypes and cerebral blood flow, as well as neurological outcomes.

Main Methods:

  • Fifty-three children diagnosed with CM were enrolled in the study.
  • CSF lactate and pyruvate levels were analyzed to calculate the LPR.
  • Transcranial Doppler ultrasound was used to assess cerebral blood flow velocities.

Main Results:

  • All 53 pediatric CM patients exhibited CMEC, with a median CSF LPR of 72.9.
  • Half of the patients were classified with ischemic CMEC (median LPR 85) and half with nonischemic CMEC (median LPR 60).
  • Ischemic CMEC was associated with significantly higher rates of low cerebral blood flow or vasospasm (73% vs. 20%) and poorer neurological outcomes (46% vs. 22%) compared to nonischemic CMEC.

Conclusions:

  • CMEC is a near-universal finding in pediatric cerebral malaria.
  • Ischemic and nonischemic CMEC subtypes have distinct associations with cerebral hemodynamics and neurological outcomes.
  • Targeting the underlying mechanisms of these CMEC subtypes may offer avenues for novel adjunctive therapies in pediatric CM.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...